| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |